Close Menu

NEW YORK – Natera said on Friday that it has filed a lawsuit against ArcherDx in the US District Court for the District of Delaware for allegedly infringing Natera's US Patent No. 10,731,220.

The patent is titled "Methods for Simultaneous Amplification of Target Loci" and was issued by the United States Patent and Trademark Office on Aug. 4, 2020. Natera said it is one of more than 200 patents issued or pending in its global intellectual property portfolio, including more than 60 in the field of oncology.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.

Time magazine looks into how liquid biopsies are changing cancer care.

According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.

In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.